etidronate has been researched along with prednisone in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (6.90) | 18.7374 |
| 1990's | 10 (34.48) | 18.2507 |
| 2000's | 10 (34.48) | 29.6817 |
| 2010's | 7 (24.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Carlton, E; Hartz, CE; Mroz, F; Rosen, C; Segal, H | 1 |
| Allen, SH; Shah, JH | 1 |
| Ibels, LS; Raper, RF | 1 |
| Gibson, R; Pettigrew, V; Turk, J; Turk, M; Waldron, D | 1 |
| Mulder, H; Snelder, AA; Struys, A | 1 |
| Sambrook, P | 1 |
| Keck, E; Stammen, D; Worth, H | 1 |
| Mulder, H; Struys, A | 1 |
| Millard, PS | 1 |
| Garcia-Delgado, I; Gil-Fraguas, L; Hawkins, F; Prieto, S; Robles, E; Rufilanchas, JJ | 1 |
| Adachi, JD; Bensen, WG; Brown, J; Chines, AA; Hanley, D; Hodsman, A; Josse, R; Kendler, DL; Lentle, B; Olszynski, W; Ste-Marie, LG; Tenenhouse, A | 1 |
| Fallon, JJ; Goldstein, MF; Harning, R | 1 |
| de Witte, SA; Hackeng, WH; Mulder, H; Smals, A; Struijs, A | 1 |
| Chidambaran, P; Ettinger, B; Pressman, A | 1 |
| Adami, S; Chines, AA; Devogelaer, JP; Reid, DM | 1 |
| Adachi, JD; Anastassiades, TP; Barton, I; Bensen, WG; Brown, JP; Chines, A; Dias, R; Hanley, DA; Hanly, JG; Hodsman, A; Ioannidis, G; Josse, R; Jovaisas, A; Kendler, DL; Lentle, B; Olszynski, WP; Pack, S; Ste-Marie, LG; Stephenson, GF; Tenenhouse, A | 1 |
| Shiraki, M | 1 |
| Koivula, MK; Konttinen, YT; Laasonen, L; Mandelin, J; Risteli, J; Valleala, H | 1 |
| Callejas-Rubio, JL; Muñoz-Torres, M; Ortego-Centeno, N; Riera-Montes, M | 1 |
| Al Dhanhani, A; Hanly, JG; Macaulay, R; Maloney, B | 1 |
| Kimura, E; Kimura, M; Kozono, Y; Yokote, Y | 1 |
| Bucci-Rechtweg, C; Devogelaer, JP; Lau, CS; Papanastasiou, P; Reginster, JY; Reid, DM; Roux, C; Saag, K; Sambrook, PN; Su, G | 1 |
| Coenen, JL; Creemers, GJ; Dalesio, O; de Jong, PC; de Wit, R; Fosså, SD; Gerritsen, W; Loosveld, OJ; Meulenbeld, HJ; Polee, M; Ten Tije, AJ; van Werkhoven, ED | 1 |
| Bucci-Rechtweg, C; Collette, J; Devogelaer, JP; Goemaere, S; Ish-Shalom, S; Papanastasiou, P; Reginster, JY; Reid, DM; Sambrook, P; Su, G | 1 |
| Blaisse, RJ; de Wit, R; Erjavec, Z; Gerritse, FL; Los, M; Meulenbeld, HJ; Roodhart, JM; Smilde, TJ; van der Velden, AM | 1 |
| Beeker, A; Bloemendal, HJ; de Klerk, JMH; Hoekstra, OS; Jonker, MA; Los, M; O'Sullivan, JM; Oprea-Lager, DE; van den Berg, HP; van den Eertwegh, AJM; van Dodewaard-de Jong, JM; Verheul, HMW | 1 |
5 review(s) available for etidronate and prednisone
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Calcinosis and metastatic calcification due to vitamin D intoxication. A case report and review.
Topics: Adult; Aluminum Hydroxide; Calcinosis; Ergocalciferols; Etidronic Acid; Humans; Joint Diseases; Male; Nephrocalcinosis; Phenytoin; Prednisone | 1992 |
Corticosteroid-induced osteoporosis.
Topics: Bone Density; Calcitonin; Calcitriol; Calcium; Etidronic Acid; Humans; Osteoporosis; Prednisone; Randomized Controlled Trials as Topic | 1994 |
Chronic glucocorticoid therapy-induced osteoporosis in patients with obstructive lung disease.
Topics: Administration, Inhalation; Administration, Oral; Adult; Alendronate; Asthma; Bone Density; Bone Remodeling; Calcitonin; Clodronic Acid; Etidronic Acid; Fluorides; Glucocorticoids; Hormone Replacement Therapy; Humans; Lung Diseases, Obstructive; Osteoporosis; Prednisone; Time Factors | 1999 |
[Risedronate: clinical usage].
Topics: Bone Density; Clinical Trials as Topic; Etidronic Acid; Femoral Neck Fractures; Fractures, Stress; Humans; Osteitis Deformans; Osteoporosis; Prednisone; Risedronic Acid; Spinal Fractures | 2002 |
15 trial(s) available for etidronate and prednisone
| Article | Year |
|---|---|
Cyclical etidronate reverses bone loss of the spine and proximal femur in patients with established corticosteroid-induced osteoporosis.
Topics: Absorptiometry, Photon; Aged; Alkaline Phosphatase; Bone Density; Calcium; Drug Administration Schedule; Etidronic Acid; Female; Femur; Humans; Male; Middle Aged; Osteoporosis; Periodicity; Phosphorus; Prednisone; Prospective Studies; Spine; Treatment Outcome | 1995 |
Therapy of steroid-induced bone loss in adult asthmatics with calcium, vitamin D, and a diphosphonate.
Topics: Adrenal Cortex Hormones; Asthma; Bone Density; Calcium; Drug Therapy, Combination; Etidronic Acid; Female; Humans; Male; Middle Aged; Osteoporosis; Prednisone; Prospective Studies; Radiography; Spinal Fractures; Vitamin D | 1994 |
Intermittent cyclical etidronate in the prevention of corticosteroid-induced bone loss.
Topics: Adrenal Cortex Hormones; Aged; Aged, 80 and over; Bone Density; Drug Administration Schedule; Etidronic Acid; Female; Giant Cell Arteritis; Humans; Middle Aged; Osteoporosis, Postmenopausal; Prednisone | 1994 |
Corticosteroid-induced bone loss.
Topics: Calcium; Etidronic Acid; Female; Femur; Follow-Up Studies; Glucocorticoids; Humans; Male; Middle Aged; Osteoporosis; Prednisone; Prospective Studies; Spine; Treatment Outcome | 1996 |
Calcitonin, etidronate, and calcidiol treatment in bone loss after cardiac transplantation.
Topics: Alkaline Phosphatase; Bone Density; Bone Diseases, Metabolic; Calcifediol; Calcitonin; Calcium; Creatinine; Etidronic Acid; Female; Heart Transplantation; Humans; Male; Middle Aged; Osteocalcin; Parathyroid Hormone; Phosphorus; Prednisone | 1997 |
Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis.
Topics: Adult; Aged; Aged, 80 and over; Bone Density; Calcium Carbonate; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Etidronic Acid; Female; Femur; Glucocorticoids; Humans; Lumbar Vertebrae; Male; Middle Aged; Osteoporosis; Prednisone; Spinal Fractures | 1997 |
Acute effects of etidronate on glucocorticoid-induced bone degradation.
Topics: Aged; Aged, 80 and over; Biomarkers; Calcium; Drug Therapy, Combination; Etidronic Acid; Female; Homeostasis; Humans; Middle Aged; Osteoporosis, Postmenopausal; Prednisone; Prospective Studies | 2000 |
Risedronate increases bone density and reduces vertebral fracture risk within one year in men on corticosteroid therapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone and Bones; Bone Density; Calcium Channel Blockers; Dose-Response Relationship, Drug; Double-Blind Method; Etidronic Acid; Humans; Male; Middle Aged; Osteoporosis; Prednisone; Risedronic Acid; Spinal Fractures; Treatment Outcome | 2001 |
Positive effect of etidronate therapy is maintained after drug is terminated in patients using corticosteroids.
Topics: Adult; Aged; Aged, 80 and over; Bone Density; Etidronic Acid; Femur Neck; Glucocorticoids; Hip; Humans; Lumbar Vertebrae; Middle Aged; Multicenter Studies as Topic; Osteoporosis; Prednisone; Randomized Controlled Trials as Topic; Spinal Fractures; Time Factors | 2001 |
Effect of cyclical intermittent etidronate therapy on circulating osteoprotegerin levels in patients with rheumatoid arthritis.
Topics: Adult; Aged; Arthritis, Rheumatoid; Arthrography; Collagen Type I; Disease Progression; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Etidronic Acid; Female; Glycoproteins; Humans; Male; Middle Aged; Osteoprotegerin; Peptide Fragments; Peptides; Prednisone; Procollagen; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor | 2003 |
Etidronate and glucocorticoid induced osteoporosis.
Topics: Asthma; Bone Density; Budesonide; Drug Therapy, Combination; Etidronic Acid; Glucocorticoids; Humans; Osteoporosis; Prednisone | 2005 |
Post hoc analysis of a single IV infusion of zoledronic acid versus daily oral risedronate on lumbar spine bone mineral density in different subgroups with glucocorticoid-induced osteoporosis.
Topics: Administration, Oral; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Bone Density; Bone Density Conservation Agents; Diphosphonates; Double-Blind Method; Drug Administration Schedule; Etidronic Acid; Female; Glucocorticoids; Humans; Imidazoles; Infusions, Intravenous; Lumbar Vertebrae; Male; Menopause; Middle Aged; Osteoporosis; Osteoporosis, Postmenopausal; Prednisone; Risedronic Acid; Sex Factors; Vitamin D; Young Adult; Zoledronic Acid | 2012 |
Randomised phase II/III study of docetaxel with or without risedronate in patients with metastatic Castration Resistant Prostate Cancer (CRPC), the Netherlands Prostate Study (NePro).
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Density Conservation Agents; Bone Neoplasms; Castration; Disease Progression; Docetaxel; Etidronic Acid; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Netherlands; Norway; Pain; Prednisone; Proportional Hazards Models; Prostate-Specific Antigen; Prostatic Neoplasms; Risedronic Acid; Risk Assessment; Risk Factors; Taxoids; Time Factors; Treatment Outcome | 2012 |
Effect on bone turnover markers of once-yearly intravenous infusion of zoledronic acid versus daily oral risedronate in patients treated with glucocorticoids.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Bone Density Conservation Agents; Diphosphonates; Drug Administration Schedule; Drug Therapy, Combination; Etidronic Acid; Female; Glucocorticoids; Humans; Imidazoles; Infusions, Intravenous; Male; Middle Aged; Osteoporosis; Prednisone; Risedronic Acid; Treatment Outcome; Zoledronic Acid | 2013 |
A randomised, phase II study of repeated rhenium-188-HEDP combined with docetaxel and prednisone versus docetaxel and prednisone alone in castration-resistant prostate cancer (CRPC) metastatic to bone; the Taxium II trial.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Disease-Free Survival; Docetaxel; Etidronic Acid; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Organometallic Compounds; Prednisone; Prostatic Neoplasms, Castration-Resistant; Taxoids | 2017 |
9 other study(ies) available for etidronate and prednisone
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Primary hyperparathyroidism in an elderly patient with multiple myeloma.
Topics: Aged; Aged, 80 and over; Calcium; Cyclic AMP; Etidronic Acid; Humans; Hypercalcemia; Hyperparathyroidism; Immunoglobulin G; Immunoradiometric Assay; Male; Melphalan; Multiple Myeloma; Parathyroid Hormone; Phosphorus; Prednisone; Ultrasonography | 1992 |
Osteosclerotic myeloma complicated by diffuse arteritis, vascular calcification and extensive cutaneous necrosis.
Topics: Adult; Aluminum Hydroxide; Arteritis; Bone Neoplasms; Calcinosis; Cyclophosphamide; Etidronic Acid; Humans; Magnesium Sulfate; Male; Multiple Myeloma; Necrosis; Plasma Exchange; Prednisone; Skin; Vascular Diseases | 1985 |
Progressive ossifying myositis in a cat.
Topics: Animals; Biopsy; Cat Diseases; Cats; Etidronic Acid; Female; Muscles; Myositis Ossificans; Prednisone; Radiography | 1985 |
Prevalence and determinants of osteoporosis drug prescription among patients with high exposure to glucocorticoid drugs.
Topics: Adult; Aged; Alendronate; Calcitonin; California; Drug Prescriptions; Drug Utilization Review; Etidronic Acid; Female; Glucocorticoids; Humans; Male; Middle Aged; Osteoporosis; Prednisone | 2001 |
Meningeal involvement in Wegener's granulomatosis.
Topics: Administration, Oral; Adult; Calcium; Cyclophosphamide; Drug Therapy, Combination; Etidronic Acid; Granulomatosis with Polyangiitis; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Meningitis; Methotrexate; Prednisone; Treatment Outcome; Vasculitis, Central Nervous System | 2006 |
Biomechanical analysis of combined treatment of high calcium and bisphosphonate in tibia of steroid-treated growing-phase rats.
Topics: Absorptiometry, Photon; Animals; Biomechanical Phenomena; Bone Density; Bone Density Conservation Agents; Bone Development; Bone Matrix; Calcium; Calcium, Dietary; Disease Models, Animal; Etidronic Acid; Imaging, Three-Dimensional; Magnesium; Male; Osteoporosis; Periosteum; Phosphorus; Prednisone; Random Allocation; Rats; Rats, Wistar; Stress, Mechanical; Tibia; Tomography, X-Ray Computed; Zinc | 2008 |
Analysis of docetaxel therapy in elderly (≥70 years) castration resistant prostate cancer patients enrolled in the Netherlands Prostate Study.
Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Docetaxel; Etidronic Acid; Humans; Male; Middle Aged; Multicenter Studies as Topic; Netherlands; Prednisone; Prostatic Neoplasms, Castration-Resistant; Randomized Controlled Trials as Topic; Retrospective Studies; Risedronic Acid; Survival Analysis; Taxoids | 2013 |